SLC16A7-HOXC13 Fusion FISH Probe
The SLC16A7-HOXC13 Fusion FISH Probe is used to confirm a fusion of the SLC16A7 and HOXC13 genes. The fusion of the SLC16A7 and HOXC13 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC16A7-HOXC13-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A7-HOXC13-20-AQAQ | 20 (40 μL) | 200 μL |
|
HOXC13 Gene Summary
This gene belongs to the homeobox family of genes. The homeobox genes encode a highly conserved family of transcription factors that play an important role in morphogenesis in all multicellular organisms. Mammals possess four similar homeobox gene clusters, HOXA, HOXB, HOXC and HOXD, which are located on different chromosomes and consist of 9 to 11 genes arranged in tandem. This gene is one of several homeobox HOXC genes located in a cluster on chromosome 12. The product of this gene may play a role in the development of hair, nail, and filiform papilla. [provided by RefSeq, Jul 2008]
Gene Name: Homeobox C13
Chromosome: CHR12: 54332575 -54340328
Locus: 12q13.13
SLC16A7 Gene Summary
This gene is a member of the monocarboxylate transporter family. Members in this family transport metabolites, such as lactate, pyruvate, and ketone bodies. The protein encoded by this gene catalyzes the proton-linked transport of monocarboxylates and has the highest affinity for pyruvate. This protein has been reported to be more highly expressed in prostate and colorectal cancer specimens when compared to control specimens. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012]
Gene Name: Solute Carrier Family 16 Member 7
Chromosome: CHR12: 60083125 -60175408
Locus: 12q14.1
Gene Diseases
The SLC16A7 HOXC13 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|